title: Ifosfamide, carboplatin, and etoposide in combination for induction and high-dose chemotherapy: focus on breast cancer and lymphoma.
authors.affiliation: Department of Internal Medicine, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa.
authors.forename: K K
authors.initials: KK
authors.lastname: Fields
authors.forename: G J
authors.initials: GJ
authors.lastname: Elfenbein
authors.forename: R A
authors.initials: RA
authors.lastname: Saleh
authors.forename: P E
authors.initials: PE
authors.lastname: Zorsky
authors.forename: W E
authors.initials: WE
authors.lastname: Janssen
authors.forename: J B
authors.initials: JB
authors.lastname: Perkins
authors.forename: T G
authors.initials: TG
authors.lastname: Saleh
authors.forename: J T
authors.initials: JT
authors.lastname: Piazza
authors.forename: L E
authors.initials: LE
authors.lastname: Kronish
authors.forename: M C
authors.initials: MC
authors.lastname: Machak
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use / Q000633:toxicity; D001943:Breast Neoplasms / Q000188:drug therapy*; D016190:Carboplatin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage*; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D016019:Survival Analysis
chemical_list: D005047:Etoposide; D016190:Carboplatin; D007069:Ifosfamide